C07D 233/48
With acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen
Official title: with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
C07D233/48 (With acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen) appears on 94 US grants and 70 published applications in this corpus.
Search patents in C07D- Granted patents
- 94
- Published applications
- 70
- Assignees
- 68
- Inventors
- 343
- Latest grant
- 2 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 6 | 0 |
| 1979 | 2 | 0 |
| 1980 | 2 | 0 |
| 1981 | 5 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 4 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 0 | 0 |
| 2002 | 4 | 3 |
| 2003 | 3 | 3 |
| 2004 | 1 | 7 |
| 2005 | 1 | 5 |
| 2006 | 1 | 2 |
| 2007 | 3 | 5 |
| 2008 | 5 | 10 |
| 2009 | 3 | 4 |
| 2010 | 3 | 4 |
| 2011 | 4 | 1 |
| 2012 | 3 | 3 |
| 2013 | 2 | 3 |
| 2014 | 2 | 1 |
| 2015 | 1 | 2 |
| 2016 | 1 | 0 |
| 2017 | 3 | 2 |
| 2018 | 1 | 7 |
| 2019 | 1 | 0 |
| 2020 | 1 | 3 |
| 2021 | 1 | 2 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Substituted imidazoles for preventing and/or treating cell or tissue necrosis2 Apr 2024US 11,945,787 B2Ela Pharma Ltd.
- Substituted thiazoles for preventing and/or treating cell or tissue necrosis6 Apr 2021US 10,968,185 B2Ela Pharma Ltd.
- WDR5-MLL1 inhibitors and modulators20 Oct 2020US 10,807,959 B2Vanderbilt University
- Substituted pyrazoles as inhibitors of fibroblast growth factor receptor26 Feb 2019US 10,214,515 B2Zhejiang Hisun Pharmaceutical Co., Ltd.
- Substituted guanidines as fungicides30 Oct 2018US 10,111,437 B2Nippon Soda Co., Ltd.
- Compositions for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto11 Sep 2025US 2025/0282740 A1Ela Pharma Ltd.
- Compositions for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto5 Sep 2024US 2024/0294480 A1Ela Pharma Ltd.
- Methods of treating alpha adrenergic mediated conditions2 Mar 2023US 2023/0062049 A1Allergan, Inc.
- Compositions and methods for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto7 Oct 2021US 2021/0309620 A1Ela Pharma Ltd.
- Tetralin and indane derivatives and uses thereof16 Sep 2021US 2021/0284606 A1Roche Palo Alto LLC
Most cited
By later US patents
- Pyridyl and naphthyridyl compounds for inhibiting osteoclast-mediated bone resorption41US 5,741,796 AMerck & Co., Inc. · 1998
- Selective neurokinin antagonists28US 6,635,630 B2Schering Corporation · 2003
- Heterocyclic compounds as P2X7 ion channel blockers25US 7,326,792 B2Aventis Pharmaceuticals Inc. · 2008
- Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent24US 5,676,978 AAmira, Inc. · 1997
- Cycloalkyl inhibitors of potassium channel function24US 7,202,253 B2Bristol-Myers Squibb Company · 2007